Juan C Ramos MD

Hematologic Oncology

Professor, Medicine, University of Miami School of Medicine

Summary

Dr. Juan C. Ramos is a hematologist-oncologist and physician scientist based in Miami, FL, specializing in lymphoma and viral related cancers. He devotes to translational research on HIV and viral related lymphomas with heavy focus on HTLV-1 related adult T-cell leukemia-lymphoma. He graduated from UCLA in 1993 where he studied Biology as an undergraduate. He graduated from UMDNJ-New Jersey Medical School in 1999, and completed his residency in internal medicine at the University of Miami/Jackson Health System in 2001, and fellowship in hematology-oncology in 2005. His expertise includes HIV/AIDS-related non-Hodgkin's lymphoma, T-cell lymphomas, and HTLV-1. Dr. Ramos has led investigator-initiated clinical trials focused on aggressive HIV or viral associated lymphomas, and has authored several publications on topics ranging from clinical to translational work. He received the Clinical Excellence Award by the International Retrovirology Association at the 2024 HTLV conference in London.

University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2001
Rutgers New Jersey Medical SchoolClass of 1999

CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

PubMed

2 citations
The UF/MSK adult mesh-based computational human phantom library: applications to organ dosimetry in computed tomography.
Robert J Dawson, Jared M Baggett, Laura E Dinwiddie, Wyatt W Smither, Yitian Wang
Physics in Medicine and Biology. 2025-11-21
MIRD Pamphlet No. 33: MIRDpvc-A Software Tool for Recovery Coefficient-Based Partial-Volume Correction.
Harry Marquis, Johan Gustafsson, C Ross Schmidtlein, Robin de Nijs, Pablo Mínguez Gabiña
Journal of Nuclear Medicine. 2025-11-03
6 citations
MIRD Pamphlet No. 32: A MIRD Recovery Coefficient Model for Resolution Characterization and Shape-Specific Partial-Volume Correction.
Harry Marquis, C Ross Schmidtlein, Robin de Nijs, Pablo Mínguez Gabiña, Johan Gustafsson
Journal of Nuclear Medicine. 2025-03-03

Abstracts/Posters

Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Stu...
Juan Carlos Ramos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
Juan Carlos Ramos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

ASH 2025 Tip Sheet: Sylvester Researchers Contribute to More Than 35 Oral Presentations at ASH Annual MeetingNovember 11th, 2025
Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024
Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024